Dual sclerostin–DKK1 antibody outperforms monotherapy

被引:0
|
作者
David Holmes
机构
关键词
D O I
10.1038/nrendo.2016.99
中图分类号
学科分类号
摘要
引用
收藏
页码:435 / 435
相关论文
共 50 条
  • [1] Sclerostin and DKK1 in Primary Hyperparathyroidism
    Ombretta Viapiana
    Elena Fracassi
    Sonila Troplini
    Luca Idolazzi
    Maurizio Rossini
    Silvano Adami
    Davide Gatti
    Calcified Tissue International, 2013, 92 : 324 - 329
  • [2] Sclerostin and DKK1 in Primary Hyperparathyroidism
    Viapiana, Ombretta
    Fracassi, Elena
    Troplini, Sonila
    Idolazzi, Luca
    Rossini, Maurizio
    Adami, Silvano
    Gatti, Davide
    CALCIFIED TISSUE INTERNATIONAL, 2013, 92 (04) : 324 - 329
  • [3] SCLEROSTIN AND DKK1 IN POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH DENOSUMAB
    Idolazzi, Luca
    Vantaggiato, Elisabetta
    Tripi, Gaia
    Giollo, Alessandro
    Dartizio, Carmela
    Povino, Maria Rosaria
    Fracassi, Elena
    Viapiana, Ombretta
    Gatti, Davide
    Rossini, Maurizio
    Adami, Silvano
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S185 - S185
  • [4] Sclerostin and DKK1 in Postmenopausal Osteoporosis Treated With Denosumab
    Gatti, Davide
    Viapiana, Ombretta
    Fracassi, Elena
    Idolazzi, Luca
    Dartizio, Carmela
    Povino, Maria Rosaria
    Adami, Silvano
    Rossini, Maurizio
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (11) : 2259 - 2263
  • [5] Optimization of sclerostin and Dkk1 neutralizing antibody ratio to maximize anabolic action in the skeleton
    Choi, Roy Byung-Jun
    Robling, Alexander
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 183 - 183
  • [6] Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume
    Alyson Morse
    Tegan L. Cheng
    Aaron Schindeler
    Michelle M. McDonald
    Sindhu T. Mohanty
    Michaela Kneissel
    Ina Kramer
    David G. Little
    Calcified Tissue International, 2018, 103 : 298 - 310
  • [7] Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume
    Morse, Alyson
    Cheng, Tegan L.
    Schindeler, Aaron
    McDonald, Michelle M.
    Mohanty, Sindhu T.
    Kneissel, Michaela
    Kramer, Ina
    Little, David G.
    CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (03) : 298 - 310
  • [8] Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition
    Witcher, Phillip C.
    Miner, Sara E.
    Horan, Daniel J.
    Bullock, Whitney A.
    Lim, Kyung-Eun
    Kang, Kyung Shin
    Adaniya, Alison L.
    Ross, Ryan D.
    Loots, Gabriela G.
    Robling, Alexander G.
    JCI INSIGHT, 2018, 3 (11):
  • [9] DKK1 and sclerostin are early markers of relapse in multiple myeloma
    Mabille, Charlotte
    Ruyssen-Witrand, Adeline
    Degboe, Yannick
    Gennero, Isabelle
    Avet-Loiseau, Herve
    Roussel, Murielle
    Hebraud, Benjamin
    Nigon, Delphine
    Attal, Michel
    Laroche, Michel
    BONE, 2018, 113 : 114 - 117
  • [10] Very low doses of sclerostin and Dkk1 neutralizing antibody are strongly anabolic if administered at the optimal ratio
    Choi, Roy
    Robling, Alexander
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 265 - 265